Company / Operating Income
IRONWOOD PHARMACEUTICALS INC Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$98.5M
FY2025
5-year range
-$945.4M / $250.3M
FY2021-FY2025
Trend
-60.7%
vs FY2024
Sector context
#39 of 204
Health Care
What the data says
IRONWOOD PHARMACEUTICALS INC's operating income of $99M is higher than 81% of companies in the Health Care sector (FY2025). Operating Income has fluctuated over the past 10 years, ranging from -$945M in FY2023 to $250M in FY2024.
Based on SEC 10-K filings.
$99M in FY2025 with a 3-year CAGR of -11.7%. Top quartile in the Health Care sector.
Improved from -$945M to $99M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -11.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
-8.6% below sector average
Key checks
Key Insights
- 3-year CAGR of -11.7%, indicating a declining trend.
- In FY2025, operating income decreased 60.7% year-over-year.
- Ranks #39 out of 204 companies in the Health Care sector.
- Peak operating income was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score -2.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $98.5M | -60.7% |
| FY2024 | $250.3M | +126.5% |
| FY2023 | -$945.4M | -761.4% |
| FY2022 | $142.9M | -38.5% |
| FY2021 | $232.3M | +254.2% |
| FY2020 | -$150.7M | -225.4% |
| FY2019 | $120.1M | +331.6% |
| FY2018 | -$51.9M | -237.6% |
| FY2017 | -$15.4M | +70.4% |
| FY2016 | -$51.9M | +49.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026